SHARE
COPY LINK

COVID-19

Pandemic in Europe won’t be over until 70 percent are vaccinated, says WHO

The WHO's European director warned Friday that the Covid-19 pandemic won't end until at least 70 percent of people are vaccinated, and criticised Europe's vaccine rollout as "too slow".

Pandemic in Europe won't be over until 70 percent are vaccinated, says WHO
A French red cross member administers a dose of the Pfizer/BioNTech vaccine to a woman at the Covid-19 vaccination centre Paris La Defense Arena in Nanterre, west of Paris on the opening day on May 3, 2021. Photo: BERTRAND GUAY / AFP

The World Health Organisation’s regional director for Europe Hans Kluge said countries and their populations must not become complacent about the pandemic.

“Don’t think the Covid-19 pandemic is over,” Kluge told AFP in an interview, while adding that vaccination rates needed to increase.

“The pandemic will be over once we reach 70 percent minimum coverage in vaccination,” the regional director said.

In the 53 countries and territories that make up the WHO’s European region — including several in Central Asia —  26 percent of the population has received a first dose of a Covid-19 vaccine.

In the European Union, 36.6 percent of the population has received at least one dose and 16.9 percent have been fully vaccinated, according to a count by AFP.

READ ALSO: COMPARE: How fast are European countries vaccinating against Covid-19?
READ ALSO: UPDATE: What rules do European countries have in place for travel from the UK?

Kluge said one of his main concerns was the increased contagiousness of new variants.

“We know, for example, that the B.1617 (Indian variant) is more transmissible than the B.117 (British variant), which was already more transmissible than the previous strain,” Kluge noted.

Cases of the so-called Indian variant have been recorded in 27 of the region’s 53 countries, while the number of new cases, and deaths, has fallen for five consecutive weeks, reaching their lowest levels since mid-October.

Speed essential
Worldwide, new cases have dropped for four weeks in a row, according to an AFP tally.

But while vaccines have proven effective against coronavirus mutations, people must still be vigilant, Kluge emphasised.

The Belgian doctor said a major concern was that “people drop their guards, that they become complacent,” especially going into the summer months.

In addition, large gatherings are on the horizon in conjunction with the European football championship.

“Let’s finally give Covid-19 the red card, don’t allow extra time for Covid-19,” Kluge quipped, repeating advice to maintain social distances and wear face masks.

He also underscored that speed is “of essence” during the pandemic.

“Our best friend is speed, time is working against us, (and) the vaccination rollout is still going too slowly,” Kluge said.
 
“We need to accelerate, we need to enlarge the number of vaccines,” and European countries needed to show more solidarity, he said.

“It is not acceptable that some countries are starting to vaccinate the younger, healthy part of the population, while other countries in our region have still not covered all the health care workers and the most vulnerable people,” he added.

Member comments

  1. hope people can memorize this claim, im really looking forward to whats going to happen when we reach 70%.

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Medical row in France over unauthorised Covid trial

French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for "the largest 'unauthorised' clinical trial ever seen" into the use of hydroxychloroquine to treat Covid-19.

Medical row in France over unauthorised Covid trial

French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for “the largest ‘unauthorised’ clinical trial ever seen” into the use of hydroxychloroquine to treat Covid-19.

Raoult, the former head of the IHU Mediterranee research hospital, and his subordinates engaged in “systematic prescription of medications as varied as hydroxychloroquine, zinc, ivermectin and azithromycin to patients suffering from Covid-19… without a solid pharmacological basis and lacking any proof of their effectiveness,” a group of 16 research bodies wrote in an op-ed piece  on daily Le Monde’s website.

The drugs continued to be prescribed “for more than a year after their ineffectiveness had been absolutely demonstrated,” they added.

Endorsement from respected tropical disease specialist Raoult helped push anti-malaria drug hydroxychloroquine into the public consciousness in the early days of the coronavirus pandemic, feeding into its promotion by former US President Donald Trump and Brazil’s then-leader Jair Bolosonaro.

In April, France’s ANSM medications authority said that treatment with hydroxichloroquine “exposes patients to potential side effects that can be serious”.

The doctors’ bodies said Sunday that authorities should take “measures appropriate to the infractions” for the sake of patient safety and “the credibility of French medical research”.

Raoult in March published a “pre-print” study — not yet submitted for scientific peer review — into treatment of more than 30,000 Covid-19 patients.

So far no one has been charged in a probe opened last year by Marseille prosecutors into fraud and unwarranted human testing at the IHU Mediterranee, based in the southern port city.

The government has also requested an investigation into the IHU’s conduct under Raoult’s management following a harsh report from inspectors.

Health Minister Francois Braun told broadcaster RTL on Sunday that he would not comment on an open investigation, but confirmed that the latest study would be included in the probe’s remit.

Raoult retired as a professor in summer 2021 and was replaced at the IHU Mediterrannee last August.

A spokesman said he remained an emeritus professor and was still supervising two doctoral students who began work on their theses before he left.

At the IHU itself, all clinical trials involving humans have been suspended since Raoult’s replacement Pierre-Edouard Fournier took over.

The hospital told AFP it was waiting for the ANSM drug regulator’s word before resuming the trials.

“The IHU has to show it has met expectations” before human testing would be allowed, the ANSM said, without setting out a timeframe.

SHOW COMMENTS